Alle Studien
Noch nicht rekrutiertPHASE2INTERVENTIONELL

Adaptive Radiotherapy for Safe Hypofractionation

This study is testing a new way of giving radiotherapy, called adaptive radiotherapy, for people with prostate, endometrial, cervical, or rectal cancer. Standard radiotherapy treatment often uses many small doses over a longer period. This new method, called 'hypofractionated' adaptive radiotherapy, uses fewer, higher doses over a shorter time. Because it uses daily scans to adjust the treatment, it can be more precise, potentially reducing side effects on healthy tissues. The main goal is to check if this new approach is as safe as current treatments, looking closely at side effects. Researchers will also be checking how well it tackles the cancer and how it affects patients' quality of life.

Auf einen Blick

Status
Noch nicht rekrutiert
Phase
PHASE2
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Einschreibeziel
264
Starten
01. Mai 2026
Geschätzte Fertigstellung
01 May 2030

Worum geht es in dieser Studie?

Imagine you have cancer and need radiotherapy. Standard radiotherapy usually involves lots of small treatment sessions. This is a very effective treatment, but because our bodies can shift slightly day to day, doctors often have to treat a slightly larger area than just the tumour to make sure they don't miss anything. This can sometimes lead to healthy tissues nearby getting some radiation, which might cause side effects.

This study is looking at a new, more advanced type of radiotherapy called 'adaptive radiotherapy.' Think of it like this: before each treatment, a special scanner checks exactly where your tumour is and if any surrounding organs have moved slightly that day. Then, the treatment plan is quickly adjusted on the spot to make sure the radiation is aimed precisely at the cancer, avoiding healthy tissues as much as possible. Because it's so precise, doctors believe they might be able to give fewer, stronger doses of radiation, which could mean fewer hospital visits for you.

The main purpose of this study is to see if this new, more flexible treatment delivers radiation just as safely as the standard method, especially in terms of side effects. We also want to see if it works just as well at treating the cancer, how it affects your quality of life, and if it makes treatment more efficient. This research could help us find better, more patient-friendly ways to treat cancer in the future.

Wichtige Erkenntnisse

  • Compares standard radiotherapy with a new 'adaptive' method.
  • Aims to make radiotherapy more precise and potentially reduce side effects.
  • Focuses on prostate, endometrial, cervical, and rectal cancers.
  • Investigating if fewer, stronger radiation doses are safe and effective.
  • Monitors side effects, cancer control, and patient well-being.
  • You would be randomly assigned to one of the two treatment groups.

Wer könnte berechtigt sein?

To join this study, you would first need to be registered in a special patient database called the PERa registry. Being part of this registry means you've already agreed to be contacted about research studies and to potentially be a 'control' participant if needed.

The study is for people with several types of cancer that affect the pelvic area, such as prostate, endometrial, cervical, and rectal cancer. Both men and women can take part, and there are no age limits mentioned.

However, there are a few reasons why some people might not be able to join, especially if they have prostate cancer. For example, if you have a medical device like a pacemaker, or certain metal implants in your hip that would interfere with MRI scans, or if you get very anxious in enclosed spaces (claustrophobia) and can't have an MRI, this study might not be suitable for you.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Are you already registered in the PERa patient database?
  2. Do you have endometrial, cervical, or rectal cancer?
  3. If you have prostate cancer, are you able to have an MRI scan?
  4. Do you not have metal implants in your hip or other pelvic metalwork that might interfere with scans?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you join this study, you will be randomly assigned to one of two groups, like flipping a coin. One group will receive the standard radiotherapy treatment that is currently used. The other group will receive the new 'adaptive hypofractionated radiotherapy.'

Both groups will have regular hospital visits for their radiotherapy sessions. If you're in the adaptive radiotherapy group, you'll have a scan before each treatment, and your plan will be adjusted based on that day's scan. The exact number of visits, assessments, and follow-ups will depend on your specific cancer type and the radiotherapy schedule you receive. The researchers will closely monitor any side effects and how well the treatment is working. You will also be asked about your quality of life.

Potenzielle Risiken und Vorteile

Potential benefits of taking part could include receiving a newer, potentially more precise radiotherapy treatment that might lead to fewer overall treatment sessions and possibly a reduction in side effects to healthy tissues. However, there are also potential risks, as this is a new approach, and researchers are still learning about it. While they aim for it to be as safe as standard treatment, there's always a chance of different or unexpected side effects. You are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Standorte (1)

  • Centre Hospitalier de l'Université de Montréal
    Verifizierte Postleitzahl
    Montreal, Kanada

Häufige Fragen

What does 'hypofractionated' mean?

It means receiving fewer, larger doses of radiation over a shorter period, compared to more, smaller doses over a longer time.

What is 'adaptive radiotherapy'?

It's a modern way of giving radiotherapy where the treatment plan is adjusted daily based on scans taken just before your session, to make it as precise as possible.

Werde ich wissen, welche Behandlung ich bekomme?

Yes, you would be told which treatment group you are in – either the standard radiotherapy or the new adaptive radiotherapy.

What types of cancer are included?

This study is for people with prostate, endometrial, cervical, or rectal cancer.

Kann ich die Studie verlassen, wenn ich meine Meinung ändere?

Yes, you can choose to leave the study at any point, and your medical care will not be affected.

Wie Sie mehr erfahren können

Mom Phat

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Interessiert daran, teilzunehmen?

Registrieren Sie Ihr Interesse

Teilen Sie Ihre Details und das Forschungsteam für "Adaptive Radiotherapy for Safe Hypofractionation… wird Sie kontaktieren, wenn Sie möglicherweise infrage kommen. Sprechen Sie immer mit Ihrem Hausarzt, bevor Sie zustimmen, teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.